— Know what they know.
Not Investment Advice
Also trades as: 0J8Z.L (LSE) · $vol 0M · ILU.DE (XETRA) · $vol 0M

ILMN NASDAQ

Illumina, Inc.
1W: +4.3% 1M: +2.8% 3M: +43.5% YTD: +108.0% 1Y: +179.2% 3Y: +140.4% 5Y: -30.6%
$279.47
+8.43 (+3.11%)
After Hours: $276.95 (-2.52, -0.90%)
Weekly Expected Move ±7.6%
$228 $249 $269 $290 $311
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 61 · $42.2B mcap · 150M float · 1.68% daily turnover · Short 59% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 5.8% of company value Bonds: $101.9M held by 175 funds, 69 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.68 (down 99.4%), Illumina, Inc. would be worth roughly what it owes.
Total debt $2.53B against a stock market value of $40.93B.
Distance to default 7.36 (Merton model): prices to 2026-10-26, balance sheet 2026-06-28, debt counted $1.25B (short-term plus half of long-term), stock volatility 48.3%; Altman Z'' 3.12. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

📊 Key Metrics

TTM
$4B
Revenue
+4.9% YoY
$825M
Net Income
-34.4% YoY
$939M
Free Cash Flow
-8.9% YoY
66.4%
Gross Margin
21.1%
Op. Margin
17.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE32.4%
ROA13.0%
ROIC18.2%

Valuation

P/E51.6
P/B14.9
EV/EBITDA20.4

Leverage

Debt/Equity0.89
Current Ratio1.80
Interest Cov.11.2x

Quality Scores

Piotroski F7/9
Altman Z5.70
Beneish M-2.56

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms